Travis C. Mickle, President & CEO at KEMPHARM, INC (KMPH), bought 10,000 shares at $0.33 ($3K) on 2020-03-05, disclosed to the SEC on 2020-03-05.
Open-market purchase of $3k KMPH by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.33 | 2,500 | $825 | 25.0% |
| 2 | $0.33 | 3,000 | $990 | 30.0% |
| 3 | $0.33 | 4,500 | $1K | 45.0% |
| Total | $0.33 avg | 10,000 | $3K | 100% |
| Filing → |
| KMPH | BUY | 2021-08-30 | $45K | — | Filing → |
| KMPH | BUY | 2021-06-14 | $22K | — | Filing → |
| KMPH | BUY | 2020-06-03 | $21K | — | Filing → |